The board of Pharmacolog resolves, subject to the approval of an extraordinary general meeting on a rights issue of units of approximately SEK 27.3 million
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATIONOF THIS PRESS RELEASE WOULD BE UNLAWFULOR WOULD REQUIRE FURTHER REGISTRATION OR ANY OTHER MEASURES. Pharmacolog i Uppsala AB (publ) ("Pharmacolog" or the "Company") announces that the board today, subject to approval from the extraordinary general meeting on 16 June 2023, has decided to